Skip to content

Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19

Effects of Physiotherapy Via Telerehabilitation on Cardiopulmonary, Physical, and Psychological Functions in Patients With COVID-19: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06251011
Enrollment
32
Registered
2024-02-09
Start date
2024-02-09
Completion date
2024-06-04
Last updated
2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Function, COVID-19, Long COVID-19, Physical Function

Brief summary

This study aims to evaluate the effects of Physiotherapy Via Video Calls on Cardiopulmonary Functions, Physical Function, Cognitive Function, Activity Daily Livings, and Quality of Life in Patients With COVID-19.

Detailed description

A 2-armed, parallel-group, randomized controlled trial was conducted at Chulabhorn Hospital, Thailand on a convenience sample of patients who tested positive for COVID-19 using RT-PCR.

Interventions

BEHAVIORALExercise training

1. Physical therapy training via video call 2. An advise and a leaflet for cardiopulmonary rehabilitation

Sponsors

Chulabhorn Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age between 20-60 years old * Positive in COVID-19 testing * Good communication and understanding * Independent mobility

Exclusion criteria

* Cannot complete the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Cardiopulmonary functionat day 28 and 90 after positive in COVID-19 testingusing Cardiopulmonary exercise testing (CPET)
Patient's quality of lifeat day 3 and 21 after positive in COVID-19 testingusing the The World Health Organization Quality of Life (WHOQOL-BREF-THAI) 26 items; the final score ranges from 24-120; higher score means participants satisfied with the quality of life.
Functional capacityat day 3 and 21 after positive in COVID-19 testingusing Duke Activity status index The final score ranges between zero and 58.2 points; The higher the score, the better the functional capacity.
Anxiety and depressionat day 3 and 21 after positive in COVID-19 testingusing Hospital Anxiety and Depression Scale (HADS) The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). A total subscale score of \>8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.
Insomniaat day 3 and 21 after positive in COVID-19 testingusing Insomnia Severity Index (ISI) The final score ranges between zero and 28 points. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
Cognitive functionat day 3 and 21 after positive in COVID-19 testingusing Thai Mental State Examination The final score ranges between zero and 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.
Muscle strengthat day 3 and 21 after positive in COVID-19 testingusing 1-minute sit to stand

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026